© 2020 MJH Life Sciences and Cure Today. All rights reserved.
© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
June 8th 2020, 8:29pm
Getting kidney cancer treatment during the COVID-19 pandemic.
June 8th 2020, 8:22pm
Kidney cancer positives that might come from this pandemic.
June 8th 2020, 8:14pm
How kidney cancer affects the risks of coronavirus.
June 8th 2020, 7:58pm
A message from the KCA’s CEO and President about COVID-19.
June 6th 2020, 5:41am
Kidney cancer changed how Tracie saw her world.
June 6th 2020, 5:22am
On his motorcycle, Stewy rides for kidney cancer.
June 6th 2020, 3:52am
A clinical trial and a positive attitude helped Bill Brown ring the bell.
June 6th 2020, 3:29am
Dawne Gee worked hard to get answers about her kidney cancer.
June 5th 2020, 11:00pm
“These results continue to support pembrolizumab (Keytruda) plus axitinib (Inlyta) as a standard of care for patients with previously untreated advanced RCC,” said lead study author Dr. Elizabeth R. Plimack.
May 30th 2020, 9:00pm
The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.